Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection

European Respiratory Journal

Volumn 25, Issue 5, 2005, Pages 911-914

  Pathmanathan, A ^a   Waterer, G W ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Outcome; Respiratory; Stenotrophomonas maltophilia; Treatment

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; MACROLIDE; TIMENTIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SPUTUM ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STENOTROPHOMONAS MALTOPHILIA; THORAX RADIOGRAPHY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL ANALYSIS; SURVIVAL RATE; WESTERN AUSTRALIA;

EID: 18744402247     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00096704     Document Type: Article

References (13)

1. Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol 1993; 43: 606-609.
2. Spencer RC. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30: Suppl. 1, 453-464.
3. Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 1996; 22: 508-512.
4. Morrison AJ, Hoffman KK, Wenzel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol 1986; 24: 52-55.
5. Fiedman ND, Korman TM, Fairley CK, et al. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 2002; 45: 47-53.
6. Senol E, DesJardin J, Stark PC, et al. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 2002; 34: 1653-1656.
7. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis 2001; 32: Suppl. 2, S104-S113.
8. Gopalakrishnan R, Hawley HB, Czachor JS, Markert RB, Bernstein JM. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: a study of 143 patients. Heart Lung 1999; 28: 134-141.
9. Valdezate S, Vinel A, Martin-Davila P, et al. High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004; 42: 693-699.
10. del Toro MD, Rodriguez-Bano J, Herrero M, et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine (Baltimore) 2004; 81: 228-239.
11. Trouillet J-L, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531-539.
12. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
13. Nicodemo AC, Araujo MR, Ruiz AS, Gales AC. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother 2004; 53: 604-608.